Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
27223 | 234 | 28.4 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
449 | 3 | FAMILIAL MEDITERRANEAN FEVER//TOLL LIKE RECEPTORS//INFLAMMASOME | 25887 |
1872 | 2 | LIPID A//ENDOTOXIN//LIPID A ANALOG | 6024 |
27223 | 1 | CONTROL INNATE IMMUN//INTEGRATED HOLIST IMMUNOL//ONO 4007 | 234 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CONTROL INNATE IMMUN | address | 1304930 | 4% | 100% | 10 |
2 | INTEGRATED HOLIST IMMUNOL | address | 1300416 | 7% | 59% | 17 |
3 | ONO 4007 | authKW | 1214585 | 5% | 85% | 11 |
4 | IP PA1 | authKW | 1056991 | 4% | 90% | 9 |
5 | BIOTECHNOL MIYAMAE KU | address | 652465 | 2% | 100% | 5 |
6 | BIOTECHNOL NOGAWA MIYAMAE KU | address | 521972 | 2% | 100% | 4 |
7 | DT 5461A | authKW | 391479 | 1% | 100% | 3 |
8 | MACROPHAGE NETWORK | authKW | 391479 | 1% | 100% | 3 |
9 | ORAL ADMINISTRATION OF LPS | authKW | 391479 | 1% | 100% | 3 |
10 | PL AQUABIOL | address | 349389 | 8% | 15% | 18 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1608 | 43% | 0% | 101 |
2 | Immunology | 281 | 18% | 0% | 42 |
3 | Pharmacology & Pharmacy | 184 | 18% | 0% | 43 |
4 | Medicine, Research & Experimental | 130 | 10% | 0% | 23 |
5 | Chemistry, Medicinal | 51 | 5% | 0% | 12 |
6 | Fisheries | 19 | 2% | 0% | 5 |
7 | Veterinary Sciences | 19 | 4% | 0% | 10 |
8 | Chemistry, Applied | 13 | 3% | 0% | 7 |
9 | Food Science & Technology | 13 | 4% | 0% | 9 |
10 | Allergy | 4 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CONTROL INNATE IMMUN | 1304930 | 4% | 100% | 10 |
2 | INTEGRATED HOLIST IMMUNOL | 1300416 | 7% | 59% | 17 |
3 | BIOTECHNOL MIYAMAE KU | 652465 | 2% | 100% | 5 |
4 | BIOTECHNOL NOGAWA MIYAMAE KU | 521972 | 2% | 100% | 4 |
5 | PL AQUABIOL | 349389 | 8% | 15% | 18 |
6 | DRUG DELIVERY SYST | 208242 | 8% | 9% | 18 |
7 | 1424 KOISHIKAWA 4 CHOME BUNKYO KU | 130493 | 0% | 100% | 1 |
8 | ANIM LIFE SCI VET HYG | 130493 | 0% | 100% | 1 |
9 | ANIM LIFE SCI VET PHYSIOL | 130493 | 0% | 100% | 1 |
10 | BIOTECHNOL 907 NOGAWA MIYAMAE KU | 130493 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GANN | 29537 | 6% | 2% | 13 |
2 | ANTICANCER RESEARCH | 12095 | 18% | 0% | 42 |
3 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 9634 | 3% | 1% | 6 |
4 | JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE | 2536 | 1% | 1% | 3 |
5 | JOURNAL OF INFLAMMATION | 1650 | 0% | 1% | 1 |
6 | INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1603 | 2% | 0% | 5 |
7 | ANTI-CANCER DRUGS | 1431 | 3% | 0% | 6 |
8 | JAPANESE JOURNAL OF CANCER RESEARCH | 1318 | 3% | 0% | 6 |
9 | JOURNAL OF PHARMACOBIO-DYNAMICS | 1275 | 2% | 0% | 4 |
10 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 1073 | 3% | 0% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ONO 4007 | 1214585 | 5% | 85% | 11 | Search ONO+4007 | Search ONO+4007 |
2 | IP PA1 | 1056991 | 4% | 90% | 9 | Search IP+PA1 | Search IP+PA1 |
3 | DT 5461A | 391479 | 1% | 100% | 3 | Search DT+5461A | Search DT+5461A |
4 | MACROPHAGE NETWORK | 391479 | 1% | 100% | 3 | Search MACROPHAGE+NETWORK | Search MACROPHAGE+NETWORK |
5 | ORAL ADMINISTRATION OF LPS | 391479 | 1% | 100% | 3 | Search ORAL+ADMINISTRATION+OF+LPS | Search ORAL+ADMINISTRATION+OF+LPS |
6 | DT 5461 | 260986 | 1% | 100% | 2 | Search DT+5461 | Search DT+5461 |
7 | HEAT KILLED ENTEROCOCCUS FAECALIS | 260986 | 1% | 100% | 2 | Search HEAT+KILLED+ENTEROCOCCUS+FAECALIS | Search HEAT+KILLED+ENTEROCOCCUS+FAECALIS |
8 | HEAT KILLED ENTEROCOCCUS FAECALIS EF 2001 | 260986 | 1% | 100% | 2 | Search HEAT+KILLED+ENTEROCOCCUS+FAECALIS+EF+2001 | Search HEAT+KILLED+ENTEROCOCCUS+FAECALIS+EF+2001 |
9 | LPSW | 260986 | 1% | 100% | 2 | Search LPSW | Search LPSW |
10 | PATHOGENIC CYTOKINES | 260986 | 1% | 100% | 2 | Search PATHOGENIC+CYTOKINES | Search PATHOGENIC+CYTOKINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | REISSER, D , JEANNIN, JF , (2009) LIPID A IN CANCER THERAPIES PRECLINICAL RESULTS.LIPID A IN CANCER THERAPY. VOL. 667. ISSUE . P. 101-110 | 30 | 56% | 4 |
2 | MATSUZAWA, T , MORI, K , KADOWAKI, T , SHIMADA, M , TASHIRO, K , KUHARA, S , INAGAWA, H , SOMA, G , TAKEGAWA, K , (2012) GENOME SEQUENCE OF PANTOEA AGGLOMERANS STRAIN IG1.JOURNAL OF BACTERIOLOGY. VOL. 194. ISSUE 5. P. 1258-1259 | 14 | 70% | 5 |
3 | REISSER, D , PANCE, A , JEANNIN, JF , (2002) MECHANISMS OF THE ANTITUMORAL EFFECT OF LIPID A.BIOESSAYS. VOL. 24. ISSUE 3. P. 284-289 | 26 | 41% | 41 |
4 | TAMURA, Y , INAGAWA, H , NAKATA, Y , KOHCHI, C , SOMA, GI , (2015) EFFECTS OF THE SUBALEURONE LAYER OF RICE ON MACROPHAGE ACTIVATION AND PROTECTION OF POLLEN ALLERGY IN A MURINE MODEL.ANTICANCER RESEARCH. VOL. 35. ISSUE 8. P. 4467 -4472 | 12 | 57% | 0 |
5 | INAGAWA, H , KOHCHI, C , SOMA, GI , (2014) USEFULNESS OF ORAL ADMINISTRATION OF LIPOPOLYSACCHARIDE FOR DISEASE PREVENTION THROUGH THE INDUCTION OF PRIMING IN MACROPHAGES.ANTICANCER RESEARCH. VOL. 34. ISSUE 8. P. 4497 -4501 | 14 | 48% | 1 |
6 | TANIGUCHI, Y , YOSHIOKA, N , NISHIZAWA, T , INAGAWA, H , KOHCHI, C , SOMA, GI , (2009) UTILITY AND SAFETY OF LPS-BASED FERMENTED FLOUR EXTRACT AS A MACROPHAGE ACTIVATOR.ANTICANCER RESEARCH. VOL. 29. ISSUE 3. P. 859-864 | 14 | 54% | 3 |
7 | DUTKIEWICZ, J , MACKIEWICZ, B , LEMIESZEK, MK , GOLEC, M , MILANOWSKI, J , (2016) PANTOEA AGGLOMERANS: A MYSTERIOUS BACTERIUM OF EVIL AND GOOD. PART IV. BENEFICIAL EFFECTS.ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE. VOL. 23. ISSUE 2. P. 206 -222 | 28 | 20% | 1 |
8 | KANASUGI, H , HASEGAWA, T , GOTO, Y , OHTSUKA, H , MAKIMURA, S , YAMAMOTO, T , (1997) SINGLE ADMINISTRATION OF ENTEROCOCCAL PREPARATION (FK-23) AUGMENTS NON-SPECIFIC IMMUNE RESPONSES IN HEALTHY DOGS.INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY. VOL. 19. ISSUE 11-12. P. 655-659 | 10 | 100% | 16 |
9 | INAGAWA, H , KOHCHI, C , SOMA, GI , (2011) ORAL ADMINISTRATION OF LIPOPOLYSACCHARIDES FOR THE PREVENTION OF VARIOUS DISEASES: BENEFIT AND USEFULNESS.ANTICANCER RESEARCH. VOL. 31. ISSUE 7. P. 2431-2436 | 16 | 36% | 9 |
10 | KOHCHI, C , INAGAWA, H , HINO, M , ODA, M , NAKATA, K , YOSHIDA, A , HORI, H , TERADA, H , MAKINO, K , TAKIGUCHI, K , ET AL (2004) UTILIZATION OF MACROPHAGES IN ANTICANCER THERAPY: THE MACROPHAGE NETWORK THEORY.ANTICANCER RESEARCH. VOL. 24. ISSUE 5C. P. 3311-3320 | 19 | 36% | 23 |
Classes with closest relation at Level 1 |